Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-22-059849
Filing Date
2022-03-01
Accepted
2022-03-01 07:46:27
Documents
78
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d234590d10k.htm   iXBRL 10-K 1969362
2 EX-4.2 d234590dex42.htm EX-4.2 12874
3 EX-10.8 d234590dex108.htm EX-10.8 61770
4 EX-10.13 d234590dex1013.htm EX-10.13 36109
5 EX-23.1 d234590dex231.htm EX-23.1 4317
6 EX-31.1 d234590dex311.htm EX-31.1 6167
7 EX-31.2 d234590dex312.htm EX-31.2 6286
8 EX-32.1 d234590dex321.htm EX-32.1 3758
14 GRAPHIC g234590g00d00.jpg GRAPHIC 132559
  Complete submission text file 0001193125-22-059849.txt   8435000

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA itci-20211231.xsd EX-101.SCH 49733
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20211231_cal.xml EX-101.CAL 50127
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20211231_def.xml EX-101.DEF 290320
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20211231_lab.xml EX-101.LAB 463727
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20211231_pre.xml EX-101.PRE 417392
72 EXTRACTED XBRL INSTANCE DOCUMENT d234590d10k_htm.xml XML 1263244
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36274 | Film No.: 22693979
SIC: 2834 Pharmaceutical Preparations